Home/Filings/4/0001209191-19-031947
4//SEC Filing

Levy Howard 4

Accession 0001209191-19-031947

CIK 0001124105other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 12:23 PM ET

Size

8.9 KB

Accession

0001209191-19-031947

Insider Transaction Report

Form 4
Period: 2019-05-21
Levy Howard
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-21$4.63/sh+4,400$20,37216,094 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-05-204,40081,218 total
    Exercise: $4.63Exp: 2027-07-11Common Stock (4,400 underlying)
  • Gift

    Common Stock

    2019-05-2116,09416,094 total(indirect: By Trust)
Footnotes (2)
  • [F1]On May 21, 2019, the reporting person transferred 16,094 directly owned shares of Company common stock to the Howard and Gillian Levy Revocable Trust dated November 21, 1994, of which the insider and his wife are trustees and beneficiaries.
  • [F2]The Option vests monthly over a period of four years commencing June 15, 2017.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001672333

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 12:23 PM ET
Size
8.9 KB